People · Operator
Named in public records as an officer, director or promoter · active 2017–2024 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| North Texas Renal Management, LLC | — | Other Health Care | Seed | $8.5M | $6.6M | 2020 |
| North Texas Renal Management V, LLC | — | Other Health Care | Pre-Seed | $1.2M | $384K | 2017 |
| North Texas Renal Management II LLC | — | Other Health Care | Pre-Seed | $808K | $3.0M | 2022 |
| North Texas Renal Management VII, LLC | — | Other Health Care | Pre-Seed | $675K | $20.8M | 2019 |
| North Texas Renal Management IV, LLC | — | Other Health Care | Pre-Seed | $659K | $20.3M | 2018 |
| North Texas Renal Management XII, LLC | — | Other Health Care | Pre-Seed | $628K | $2.9M | 2024 |
| North Texas Renal Management IX, LLC | — | Other Health Care | Pre-Seed | $534K | $16.5M | 2019 |
| North Texas Renal Management VIII, LLC | — | Other Health Care | Pre-Seed | $513K | $15.8M | 2018 |
| North Texas Renal Management VI, LLC | — | Other Health Care | Pre-Seed | $489K | $15.1M | 2018 |
Geoffrey Walker, M.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Geoffrey Walker, M.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.